FDA approves Fitbit emergency ventilator 

The FDA granted Fitbit emergency use authorization for its new emergency ventilator, which it developed with help from Boston-based Massachusetts General Brigham and Portland-based Oregon Health & Science University. 

Advertisement

The Fitbit Flow ventilator is approved for use to treat COVID-19 patients specifically and is intended as temporary or short-term support when a commercial ventilator is unavailable. 

The device builds on the design of standard resuscitator bags used by paramedics and incorporates instruments, sensors and alarms to support automated compressions and patient monitoring. 

More articles on digital transformation: 
NYU develops app that uses biomarkers, AI to generate patient COVID-19 severity scores
Brigham and Women’s Hospital, MIT create system that customizes air supply for patients sharing ventilator 
AI, facial recognition & virtual communication: How 4 health systems are using tech to guide return to workplace

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.